The HCPLive Gastroenterology condition center page is a comprehensive resource for clinical news and insights on digestive and GI conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for C difficile, IBS and IBD, Crohn's disease, and more.

Latest News

(Left to right) Byron Vaughn, MD, MS; Osama Altayar, MD; Colleen Kelly, MD | Credit: Fairview Health; Washington University; Brigham and Women’s Hospital
Experts’ Perspectives: AGA Recommends FMT for C Diff

February 21st 2024

Investigators from the guideline panel discuss the AGA’s recommendations regarding the use of fecal microbiota-based therapies for CDI, IBD, and IBS.

Anne Peery, MD | Credit: UNC School of Medicine
AGA Supports Fecal Microbiota-Based Therapies for C Diff in New Guideline

February 21st 2024

Vincent Chi-ho Chung, PhD, MSc | Credit: JC School of Public Health and Primary Care
Engaging in More Healthy Lifestyle Behaviors May Reduce Risk of IBS

February 20th 2024

Karl Mårild, MD, PhD | Credit: University of Gothenburg
Histological, Clinical Disease Activity Linked to Reduced Fertility in Women with IBD

February 20th 2024

Black and white FDA logo | Credit: US Food and Drug Administration
FDA Approves Budesonide Oral Suspension (Eohilia) for Eosinophilic Esophagitis

February 12th 2024

Latest CME Events & Activities

The Next Wave in Biliary Tract Cancers: Leveraging Immunogenicity to Optimize Patient Outcomes in an Evolving Treatment Landscape

View More

9th Annual School of Gastrointestinal Oncology® (SOGO®)

February 24, 2024

Register Now!

Show Me the Data! Navigating FGFR, FGFR Resistance, Immunotherapy, and a World of Clinical Trials in Cholangiocarcinoma Treatment

View More

4th Annual Live Medical Crossfire® IBS and IBD

View More

Expert Illustrations & Commentaries™: A Closer Look at Emerging Therapies in IBS-C

View More

Advances In™ KRAS Inhibition: Modern Considerations In Targeting KRAS-Mutated Lung, Colorectal, And Pancreatic Cancers

View More

Medical Crossfire®: Critical Questions on Diagnosis, Sequencing, and Selection of Systemic and Radioligand Therapy Options for Patients with GEP-NETs

View More

Rapid Oncology Abstract Review®: Key Updates in Gastrointestinal Cancers from the ASCO Annual Meeting

View More

Medical Crossfire®: Bridging Precision Medicine Techniques and Emerging Treatments in Metastatic Colorectal Cancer

View More

"REEL" Time Patient Counseling™: Integrating Biosimilars into the Clinical Conversation

View More

Burst CME: Incorporating the Latest Updates in IBS Treatment into Your Practice

View More

Advancing Care in Erosive Esophagitis: Towards a Path of Complete Healing

View More

Community Practice Connections™: 8th Annual School of Gastrointestinal Oncology®

View More

Cancer Summaries and Commentaries™: Clinical Updates in RCC from Chicago

View More

Oncology Town Hall: Live Report from Barcelona for Advances in the Treatment of GI Cancers

View More

Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency

View More

2024 Miami International Symposium of Gastrointestinal Oncology (ISGIO)

October 11-12, 2024

Register Now!

Community Practice Connections™: 20th Annual Meeting of the International Society of Gastrointestinal Oncology®

View More

Working Group: Streamlining the Pathway from Diagnosis to Treatment in Inflammatory Bowel Disease

View More

Advances In™: The Evolving Role of VEGFR in the Treatment of Refractory mCRC

View More

41st Annual CFS®: Innovative Cancer Therapy for Tomorrow

View More

Show Me the Data: Bridging Clinical Gaps in Later Lines of Metastatic CRC… It’s Easy as VEGFR1, 2, 3!

View More

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

More News

© 2024 MJH Life Sciences

All rights reserved.